A meta-analysis of survival of patients with second primary non-small cell lung cancer after pulmonary lobectomy and partial pulmonary lobectomy

Am J Transl Res. 2021 Apr 15;13(4):2422-2431. eCollection 2021.

Abstract

Objective: A meta-analysis of the screened data was performed to investigate the survival status of patients with second primary non-small cell lung cancer (SPNSCLC) after pulmonary lobectomy and partial pulmonary lobectomy, and assess the applicability of such option in the treatment of such disease.

Methods: Based on the databases of PubMed, Ovid, and CNKI, relevant reports on postoperative survival of patients with SPNSCLC were obtained, and the information, including authors, publication year, research type, tumor staging, tumor diameter, surgical options, reasons for resection, and overall survival (OS), was extracted. The data were analyzed using Review Manager 5.3.

Results: A total of 11 studies published from 2010 to 2017 were collected. Patients with SPNSCLC were mainly in stage Ia and Ib, 51.4% of whom underwent pulmonary lobectomy and 34.7% of whom underwent partial pulmonary lobectomy. The analysis results showed that after the second lobectomy, the mortality rate of the patients undergoing intensive surgery was 8%, the incidence of postoperative complications was 29%, and the 5-year OS rate was 53% after the second lobectomy for patients with SPNSCLC.

Conclusion: The survival rate of patients with SPNSCLC is lower than that of patients with early lung cancer. In view of this, surgical resection is feasible. There are remarkable differences between pulmonary lobectomy and partial pulmonary lobectomy.

Keywords: Lung cancer; meta-analysis; partial pulmonary lobectomy.

Publication types

  • Review